Focus on nasopharyngeal carcinoma

Chan, 2000, High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese, Cancer Res., 60, 5365

Chan, 2002, Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese, Int. J. Cancer, 102, 300, 10.1002/ijc.10689

Chan, 2002, Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma, J. Natl. Cancer Inst., 94, 1614, 10.1093/jnci/94.21.1614

Chien, 2001, Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men, N. Engl. J. Med., 345, 1877, 10.1056/NEJMoa011610

Cho, 2003, Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1, Cancer Epidemiol. Biomarkers Prev., 12, 1100

Chow, 2004, RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma, Int. J. Cancer, 109, 839, 10.1002/ijc.20079

Crook, 2000, High level expression of ΔN-p63, Oncogene, 19, 3439, 10.1038/sj.onc.1203656

Ferlay, J., Bray, F., Pisani, P., and Parkin, D.M. (2001). GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. (Lyon: IARC Press).

Feng, 2002, Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4, Nat. Genet., 31, 395, 10.1038/ng932

Feng, 2002, Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate early protein BZLF1 or BRLF1 to treat EBV-positive tumors, J. Virol., 76, 10951, 10.1128/JVI.76.21.10951-10959.2002

Feng, 2002, Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors, Cancer Res., 62, 1920

Hildesheim, 1997, CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan, J. Natl. Cancer Inst., 89, 1207, 10.1093/jnci/89.16.1207

Hildesheim, 2002, Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan, J. Natl. Cancer Inst., 94, 1780, 10.1093/jnci/94.23.1780

Huang, 1978, Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish, 315

Hui, 1999, Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization, Int. J. Cancer, 48, 498, 10.1002/(SICI)1097-0215(19990812)82:4<498::AID-IJC5>3.0.CO;2-S

Hui, 2002, Coexpression of hypoxia-inducible factors 1 alpha and 2 alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival, Clin. Cancer Res., 8, 2595

Hui, 2003, Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma, Mol. Carcinog., 38, 170, 10.1002/mc.10156

Jayasurya, 2000, Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma, Br. J. Cancer, 82, 1198, 10.1054/bjoc.1999.1063

Kwong, 2002, Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma, Clin. Cancer Res., 8, 131

Lee, 1999, Staging of nasopharyngeal carcinoma, Int. J. Cancer, 84, 179, 10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6

Lee, 2000, CTL control of EBV in nasopharyngeal carcinoma (NPC), J. Immunol., 165, 573, 10.4049/jimmunol.165.1.573

Lee, 2003, Changing epidemiology of nasopharycarcinoma in Hong Kong over a 20-year period (1980–99), Int. J. Cancer, 103, 680, 10.1002/ijc.10894

Li, 2002, Tumor-targeted gene therapy for nasopharyngeal carcinoma, Cancer Res., 62, 171

Lin, 2002, Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma, Cancer Res., 62, 6952

Liu, 2002, Novel gene therapy approach for nasopharyngeal carcinoma, Semin. Cancer Biol., 12, 505, 10.1016/S1044579X02000937

Lo, 2002, Genetic and epigenetic changes in nasopharyngeal carcinoma, Semin. Cancer Biol., 12, 451, 10.1016/S1044579X02000883

Lo, 1996, Hypermethylation of the p16 gene in nasopharyngeal carcinoma, Cancer Res., 56, 2721

Lo, 1999, Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma, Cancer Res., 59, 5452

Lo, 2000, High resolution allelotype of microdissected primary nasopharyngeal carcinoma, Cancer Res., 60, 3348

Lo, 2000, Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA, Cancer Res., 60, 6878

Lo, 2001, High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma, Cancer Res., 61, 3877

Lo, 2004, Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117–LMP1) in nasopharyngeal epithelial cells, Int. J. Cancer, 109, 919, 10.1002/ijc.20051

Lu, 1990, Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region, Nature, 346, 470, 10.1038/346470a0

Lu, 1993, Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma, Int. J. Cancer, 53, 29, 10.1002/ijc.2910530107

Lu, 2003, Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins, Cancer Res., 63, 256

Marks, 1998, The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma, Cancer, 83, 582, 10.1002/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-R

Nazar-Stewart, 1999, Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma, Cancer Epidemiol. Biomarkers Prev., 8, 547

Qian, 2002, Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma, Cancer Res., 62, 589

Raab-Traub, 2002, Epstein-barr virus in the pathogenesis of NPC, Semin. Cancer Biol., 12, 431, 10.1016/S1044579X0200086X

Raab-Traub, 1986, The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation, Cell, 47, 883, 10.1016/0092-8674(86)90803-2

Shanmugaratnam, K., and Sobin, L.H. (1991). Histology Typing of Tumours of the Upper Respiratory Tract and Ear, 2nd ed. (Berlin: Springer-Verlag).

Teo, 2002, Treatment strategy and clinical experience, Semin. Cancer Biol., 12, 497, 10.1016/S1044579X02000925

Thornburg, 2003, Activation of nuclear factor-κB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma, Cancer Res., 63, 8293

Tong, 2002, Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma, Clin. Cancer Res., 8, 2612

Tong, 2003, Re, J. Natl. Cancer Inst., 95, 1008, 10.1093/jnci/95.13.1008

Wang, 1999, Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma, Br. J. Cancer, 81, 1122, 10.1038/sj.bjc.6690818

Wang, 2002, Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells, Mol. Carcinog., 35, 42, 10.1002/mc.10072

Wei, 1997, Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus, Oncogene, 14, 3073, 10.1038/sj.onc.1201128

Wong, 2004, Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma, Clin. Cancer Res., 10, 2401, 10.1158/1078-0432.CCR-03-0139

Xiong, 2004, A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma, Cancer Res., 64, 1972, 10.1158/0008-5472.CAN-03-3253

Yu, 2002, Epidemiology of nasopharyngeal carcinoma, Semin. Cancer Res., 12, 421

Zeng, 1985, Seroepidemiological studies on nasopharyngeal carcinoma in China, Adv. Cancer Res., 14, 121, 10.1016/S0065-230X(08)60027-5